Product Detail

loading

Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

CAS No.185411-11-4, methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bisl(tert- butyldimethylsilyl)oxy)-6- ((S,E)-1-((tert- tutyldimthylsilyl)jxy)-3- (trimethylsilylallyl)octahydropyrano[3,2-blpyran 2-yl)acetate

  • 185411-11-4

  • C35H72O7Si4

  • 717.28

  • N/A

  • 99% min

  • N/A

  • N/A

  • N/A

  • L (Breast cancer; sarcoma; liposarcoma)

  • Eribulin

Availability:
Inquire

CAS No.185411-11-4, methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bisl(tert- butyldimethylsilyl)oxy)-6- ((S,E)-1-((tert- tutyldimthylsilyl)jxy)-3- (trimethylsilylallyl)octahydropyrano[3,2-blpyran 2-yl)acetate

Synthetic Roadmap

Eribulin-1-1~12Eribulin-2-13~18Eribulin-7-46~58Eribulin-8-55~66Eribulin-9-67~37


Are also in this series, click those CAS No. above

To check details


Illustrate

For the synthesis of Eribulin, Eribulin belongs to a new type of drug for the treatment of breast cancer. We offer high purity, kilogram production.


Download

Previous: 
Next: 
CAS No.185411-11-4